Both MET gene amplification and exon 14 skipping mutations are present in all major histologic types of lung cancers, including adenocarcinoma, squamous, adenosquamous, large cell and small cell [15, 16, 18], but are more frequently found in adenocarcinoma and adenosquamous respectively [15, 16, 19]. This evidence concerns the gene MET and lung cancer.